Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma
Illumina and PHASE Partner to Advance Oncology Testing in the Greater Bay Area, Supporting the "Healthy China" Initiative
MGI Partners with Human Cell Atlas to Advance Global Human Cell Mapping
NHS Wales and Illumina Expand Partnership to Advance Genomic Cancer Detection and Personalized Medicine
Unlocking Genomic Potential for Rare Cancers: Cancer52 and Genomics England’s Collaborative Approach
Tempus AI Launches Immune Profile Score to Enhance Precision in Immunotherapy for Advanced Cancer Patients
Key Resources and Organizations for Precision Medicine Guidelines
MedGenome Strengthens Leadership Team to Drive North American Expansion in Precision Medicine
NCCN Expands Clinical Practice Guidelines for High-Risk Genetic Cancer Assessment
MicrobioTx Launches Gut Function Test (GFT) for Easy, Affordable Gut Health Profiling
Roche to Present Over 40 Abstracts on Blood Disorders at 66th ASH Annual Meeting, Showcasing Advances in Lymphoma Treatments
Hamad Medical Corporation Hosts 3rd Precision Medicine Conference on AI and Genomics Integration
Caris Life Sciences Receives FDA Approval for Groundbreaking MI Cancer Seek™ Diagnostic Assay for Precision Oncology
IWG Proposes New Clinical-Biological Definition for Diagnosing Alzheimer’s Disease
Inify Laboratories and Karolinska Institutet's ProMort Team Partner to Transform Prostate Cancer Diagnostics with AI
Your email address will not be published. Required fields are marked *